An Open Label, Randomised, Parallel Group Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Relvar/Breo ELLIPTA Therapy, in Asthmatic Subjects With Poor Control
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2019
Price : $35 *
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 21 Feb 2019 Status changed from recruiting to completed.
- 19 Feb 2019 This trial has been completed in Germany (End date: 2019-01-24), according to the European Clinical Trials Database record
- 02 Feb 2019 This trial has been completed in Spain, according to the European Clinical Trials Database record.